Effectiveness of video-assisted thoracoscopic surgery with blebectomy and mechanical pleural abrasion in the treatment of primary spontaneous pneumothorax: a retrospective long-term single-centre analysis

视频辅助胸腔镜手术联合肺大疱切除术和机械性胸膜磨削术治疗原发性自发性气胸的疗效:一项回顾性长期单中心分析

阅读:1

Abstract

BACKGROUND: The etiology of primary spontaneous pneumothorax (PSP) is not fully understood, with factors such as subpleural blebs, bullae, visceral pleural porosity, and smoking implicated in its development and recurrence. This study evaluates the short- and long-term outcomes of video-assisted thoracoscopic surgery (VATS), including blebectomy, bullectomy, and pleural abrasion in PSP management. PATIENTS AND METHODS: A retrospective analysis was conducted on 80 consecutive patients diagnosed with PSP who underwent VATS blebectomy and mechanical pleural abrasion between 2010 and 2023. Data on patient demographics, surgical interventions, and postoperative outcomes were systematically collected and analysed. RESULTS: Of the 80 patients with PSP, 53 (66.3%) were male and 27 (33.8%) female; 36 had right-sided and 44 left-sided PSP. Chest pain and dyspnoea were the predominant symptoms. Sixty-one patients were hemodynamically stable, while 19 presented unstable. Thirty-six had small and 44 had large pneumothoraces. High-resolution computed tomography showed a Dystrophy Severity Score (DSS) of 0-3 in 41 patients and 4-6 in 39. All underwent VATS (87.5% two-port, 12.5% three-port) without conversion to thoracotomy. Surgical management included bleb/bulla excision (78/80) and pleural abrasion (100%). Complications were uncommon: pneumonia (n = 2), residual hemothorax (n = 1), intercostal neuralgia (n = 2). During the 36-month follow-up, two recurrences occurred, one requiring repeat VATS. No postoperative mortality was observed, confirming the safety and efficacy of VATS. CONCLUSION: VATS blebectomy with pleural abrasion is a safe treatment for PSP, offering effective lung re-expansion with low complications and recurrence. Further prospective studies are needed to validate these findings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。